Date Published
Country
Source
Videos
-
Understanding America’s Evolving Healthcare Ecosystem
Healthcare in the U.S. is a lot of things—innovative, expensive, complicated. From sprawling hospital systems to local minute clinics to the labs around the world developing COVID vaccines, what goes on behind the scenes? -
How Tainted Pills Got Into America's Drug Supply
Gaps in how the U.S. Food and Drug Administration evaluates the safety of generic drugs allowed cancer-causing impurities to end up in blood pressure pills taken by many Americans.Comments
No comments yet. Create an account and log in to post a comment.
-
Financial Toxicity of Cancer Treatment: An Overview
Dr. Chino discusses the financial impact of cancer treatment on survivors and proposes potential solutions.Comments
No comments yet. Create an account and log in to post a comment.
-
Launch of the European Fair Pricing Network EFPN
Cancer societies and the Norwegian Ministry of Health and Care Services officially launched the long-awaited European Fair Pricing Network (EFPN).Comments
No comments yet. Create an account and log in to post a comment.
-
The Power of the Pharmaceutical Companies
How much is a human life worth? An innovative cancer therapy promises to save lives. But it is extremely expensive.Comments
No comments yet. Create an account and log in to post a comment.
-
Bristol Myers CEO on Company's Cancer Treatment Pipeline
Bristol Myers Squibb CEO Dr. Giovanni Caforio joins "Squawk on the Street" to discuss the importance of the American Society of Clinical Oncology annual meeting in order to advance cancer research.Comments
No comments yet. Create an account and log in to post a comment.
-
Coronavirus: PM Announcing Strict New Curbs on Life in UK
The prime minister is announcing strict new curbs on life in the UK to tackle the spread of coronavirus.Comments
No comments yet. Create an account and log in to post a comment.
-
Cancer Drugs Routinely Thrown Out, Wasting Millions of Dollars per Year: Study
The health-care system is wasting millions of dollars by buying cancer medications that are thrown out because of the way they are packaged by drug makers.Comments
No comments yet. Create an account and log in to post a comment.
-
The Rare Disease Drug Dilemma: Great Value, High Price, Limited Access?
Drugs to treat rare diseases were once immune to patient access management strategies due to the high unmet need, few, if any, treatment options, and small patient populations.Comments
No comments yet. Create an account and log in to post a comment.
-
A 'Take-Back' Program
A program allows for cancer treatment medications to be donated back for use, reducing cost.Comments
No comments yet. Create an account and log in to post a comment.
-
'We're expecting to get at least six drug approvals from the FDA in 2020': GlaxoSmithKline CEO
GlaxoSmithKline CEO Emma Walmsley told "Mad Money" host Jim Cramer the British drugmaker has received "positive data" for cancer and HIV drugs.Comments
No comments yet. Create an account and log in to post a comment.
-
Bristol-Myers Squibb CEO on the Drug Pipeline, 2020 Outlook and More
Bristol-Myers Squibb CEO Dr. Giovanni Caforio sits down with CNBC's Jim Cramer at the J.P. Morgan Healthcare Conference in San Francisco.Comments
No comments yet. Create an account and log in to post a comment.
-
Who do We Need to Make the Medicines of the Future?
Pharmaceutical companies around the world are pioneering new medicines and vaccines.Comments
No comments yet. Create an account and log in to post a comment.
-
Is it Time to Change the Way We Fight Cancer?
Billions of dollars and countless hours of research have been poured into fighting the scourge of cancer. But the work has yielded little tangible benefit.Comments
No comments yet. Create an account and log in to post a comment.
-
Dr. Richard Pazdur says FDA Looks at Safety and Efficacy, Not Costs When Evaluating Drugs
Dr. Richard Pazdur, director of The Oncology Center of Excellence at the U.S. Food and Drug Administration, says that the FDA is “agnostic” when it comes to drug pricing.Comments
No comments yet. Create an account and log in to post a comment.
Comments